Comparative Study Between Pulse Therapy With Oral Itraconazole Versus

Status Completed

Clinical Trial Summary

Nail fungus, often known as onychomycosis (OM), can attack either the toenails or the fingernails. Onychomycosis can affect the matrix, the nail bed, or the nail plate. Though not fatal, onychomycosis is a significant condition that can impede a person's mobility and ability to work. Onychomycosis's wide-ranging emotional and social impacts can have a serious negative impact on patients' well-being. White superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), endonyx onychomycosis (EO), and candidal onychomycosis are the most common subtypes of onychomycosis. A patient may exhibit characteristics from more than one of these categories. A severe case of onychomycosis, regardless of its subtype, is called total dystrophic onychomycosis. Different types of onychomycosis have different pathophysiology. The most frequent type of onychomycosis, known as distal lateral subungual onychomycosis, occurs when a fungus travels from the plantar skin to the nail bed through the hyponychium. These sections of the nail apparatus become inflamed, leading to the outward manifestations of distal lateral subungual onychomycosis. White superficial onychomycosis, on the other hand, is a less common presentation produced by invasion of the nail plate's surface. Fungi colonise the deep section of the proximal nail plate in the rare condition known as proximal subungual onychomycosis. When the fungi infect the nail through the skin and penetrate the nail plate, the result is known as endonyx onychomycosis, a subtype of distal lateral onychomycosis. Over and over again, terbinafine has been shown to be more effective than other antifungal medicines in clinical trials. Mycological cure rates for onychomycosis were 76% with terbinafine, 63% with pulse itraconazole, and 48% with fluconazole, according to a meta-analysis of 18 studies. The aim of this study is to determine the aim of this study is to compare pulse therapy with oral itraconazole versus continuous oral terbinafine for treatment of onychomycosis

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Onychomycosis

Clinical Trial Details

NCT number	NCT05578950
Study type	Interventional
Source	Combined Military Hospital Abbottabad
Contact
Status	Completed
Phase	Phase 1
Start date	March 1, 2022
Completion date	August 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03098615` - Study Evaluating the Effect of Jublia on Dermatophytomas	Phase 4
Recruiting	`NCT01666002` - Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser	N/A
Completed	`NCT01180491` - A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis	N/A
Terminated	`NCT01208129` - Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Terminated	`NCT01208168` - Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Completed	`NCT00385502` - A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail	Phase 2
Completed	`NCT00253305` - Topical Gel Anti-Fungal Agent for Tinea Unguium	Phase 2
Not yet recruiting	`NCT05809297` - Diode Laser and Photodynamic Therapy Vs. Ciclopirox.	Phase 4
Completed	`NCT03405818` - An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents	Phase 4
Completed	`NCT02588599` - A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis	N/A
Recruiting	`NCT02436291` - Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis	Phase 4
Completed	`NCT01851590` - Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis	Phase 4
Completed	`NCT01452490` - Diode Laser Treatment of Onychomycosis	N/A
Withdrawn	`NCT00938925` - Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)	N/A
Recruiting	`NCT00808366` - Efficacy and Safety of RV4104A Ointment in Onychomycosis	N/A
Completed	`NCT00781820` - Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste	Phase 3
Completed	`NCT00768768` - Iontophoretic Application of Terbinafine Gel to the Large Toe Nail	Phase 1
Completed	`NCT00777868` - A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis	Phase 2
Recruiting	`NCT06074315` - Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis	N/A
Completed	`NCT01039883` - A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms